Clinical trial
A Non-interventional Observation Study to Evaluate Immune Responses Following Seasonal Influenza Vaccine in Participants With Relapsing Multiple Sclerosis Treated With Cladribine Tablets
NCT05019248 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Observation Study to Evaluate Immune Responses Following Seasonal Influenza Vaccine in Participants With Relapsing Multiple Sclerosis Treated With Cladribine Tablets
- Lead sponsor
- Heinrich-Heine University, Duesseldorf
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2020
- Completion date
- April 30, 2022
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple sclerosis, relapsing-remitting, vaccine response impaired